MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

The latest financial statement is for the year ending 2025-12-31.

Cash Flow Overview

Free Cash flow
-$62,063K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
    • Maturities of available-for-sale...
    • Proceeds from issuance of common...
    • Prepaid expenses and other asset...
    • Others
Negative Cash Flow Breakdown
    • Purchases of available-for-sale ...
    • Accretion of discount of availab...
    • Operating lease liability
    • Others

Cash Flow
2025-12-31
Consolidated net loss
-74,123
Depreciation and amortization
664
Stock-based compensation
4,997
Accretion of discount of available-for-sale investment securities
1,854
Amortization of right-of-use assets
889
Gain on disposal of property and equipment
12
Other receivables
-863
Prepaid expenses and other assets
-7,334
Accounts payable and accrued expenses
-33
Operating lease liability
-711
Net cash used in operating activities
-61,986
Purchases of property and equipment
77
Purchases of available-for-sale investment securities
93,445
Maturities of available-for-sale investment securities
88,457
Proceeds from sale of property and equipment
12
Net cash (used in) provided by investing activities
-5,053
Proceeds from issuance of common stock through option exercises
19
Proceeds from issuance of common stock through employee stock purchase plan
108
Proceeds from issuance of common stock from at-the-market offerings, net of offering costs
66,423
Proceeds from issuance of common stock from underwritten follow-on public offering, net of offering costs
0
Principal paid on finance lease liabilities
539
Net cash provided by financing activities
66,011
Net change in cash, cash equivalents and restricted cash
-1,028
Cash, cash equivalents and restricted cash at beginning of period
14,006
Cash, cash equivalents and restricted cash at end of period
12,978
Unit: Thousand (K) dollars (except for numbers of shares and EPS).

Time Plot

Show the time plot by selecting a row from the table.

Cash Flow

Proceeds from issuance ofcommon stock from...$66,423K Proceeds from issuance ofcommon stock through...$108K Proceeds from issuance ofcommon stock through...$19K Net cash provided byfinancing activities$66,011K Canceled cashflow$539K Net change in cash,cash equivalents and...-$1,028K Canceled cashflow$66,011K Prepaid expenses andother assets-$7,334K Stock-based compensation$4,997K Amortization of right-of-useassets$889K Other receivables-$863K Depreciation andamortization$664K Maturities ofavailable-for-sale investment...$88,457K Proceeds from sale ofproperty and equipment$12K Principal paid on financelease liabilities$539K Net cash used inoperating activities-$61,986K Canceled cashflow$14,747K Net cash (used in)provided by investing...-$5,053K Canceled cashflow$88,469K Consolidated net loss-$74,123K Accretion of discount ofavailable-for-sale investment...$1,854K Operating lease liability-$711K Accounts payable andaccrued expenses-$33K Gain on disposal ofproperty and equipment$12K Purchases ofavailable-for-sale investment...$93,445K Purchases of property andequipment$77K

aTYR PHARMA INC (ATYR)

aTYR PHARMA INC (ATYR)